Abstract
Purpose of the Review
To provide an overview of current interventional pain management techniques for primary headaches with a focus on peripheral nerve stimulation and nerve blocks.
Recent Findings
Despite a plethora of treatment modalities, some forms of headaches remain intractable to conservative therapies. Interventional pain modalities have found a niche in treating headaches. Individuals resistant to common regimens, intolerant to pharmaceutical agents, or those with co-morbid factors that cause interactions with their therapies are some instances where interventions could be considered in the therapeutic algorithm. In this review, we will discuss these techniques including peripheral nerve stimulation, third occipital nerve block (TON), lesser occipital nerve block (LON), greater occipital nerve block (GON), sphenopalatine block (SPG), radiofrequency ablation (RFA), and cervical epidural steroid injections (CESI).
Summary
Physicians have used several interventional techniques to treat primary headaches. While many can be treated pharmacologically, those who continue to suffer from refractory or severe headaches may see tremendous benefit from a range of more invasive treatments which focus on directly inhibiting the painful nerves. While there is a plethora of evidence suggesting these methods are effective and possibly durable interventions, there is still a need for large, prospective, randomized trials to clearly demonstrate their efficacy.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Ahmed F. Headache disorders: differentiating and managing the common subtypes. Br J Pain. 2012;6(3):124–32.
Wahezi SE, Silva K, Shaparin N, Lederman A, Emam M, Haramati N, et al. Currently recommended TON Injectate volumes concomitantly block the GON: clinical implications for managing cervicogenic headache. Pain Physician. 2016;19(7):E1079–86.
•• Levin M. The International Classification of Headache Disorders, (ICHD III)–changes and challenges. Headache. 2013;53(8):1383–95. This artcle provides rationale behind ICHD classification, a guide to its use; and summary of improtant diagniostic features.
Nelson S, Taylor LP. Headaches in brain tumor patients: primary or secondary? Headache. 2014;54(4):776–85.
Lipton R, Bigal M, Steiner T, Silberstein S, Olesen J. Classification of primary headaches. Neurology. 2004;63(3):427–35.
Franco AL, Gonçalves DA, Castanharo SM, Speciali JG, Bigal ME, Camparis CM. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain. 2010;24(3).
•• Becker WJ. Cervicogenic headache: evidence that the neck is a pain generator. Headache. 2010;50(4):699–705. This article takes a pro stance that abnormalities in the neck is a significant source of headache, particlarly the upper cervical zygophyseal joints.
Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet. 2009;373(9670):1198–206.
Bogduk N, Windsor M, Inglis A. The innervation of the cervical intervertebral discs. Spine (Phila Pa 1976). 1988;13(1):2–8.
Wu B, Yang L, Peng B. Ingrowth of nociceptive receptors into diseased cervical intervertebral disc is associated with discogenic neck pain. Pain Med. 2019.
• Peng B, Bogduk N. Cervical discs as a source of neck pain. An analysis of the evidence. Pain Med. 2019;20(3):446–55. This article describes basic science evidence that cervical discs contain nociceptive innervation and potentially be an important source of neck pain.
Özge A, Termine C, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part I: diagnosis. J Headache Pain. 2011;12(1):13–23.
Koehler PJ, Boes CJ. A history of non-drug treatment in headache, particularly migraine. Brain. 2010;133(8):2489–500.
•• Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32(16):1165–79. In a randomized study investigators demonstrate that there was no difference between active and control group as far as PNS is concerned but showed 30% reduction (as opposed to 50%) in pain, decrease in headache days and improvement in diasbility.
Popeney CA, Aló KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003;43(4):369–75.
Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127(1):220–30.
Schwedt T, Dodick D, Hentz J, Trentman T, Zimmerman R. Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia. 2007;27(2):153–7.
Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271–85.
Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–21.
•• Mekhail NA, Estemalik E, Azer G, Davis K, Tepper SJ. Safety and efficacy of occipital nerves stimulation for the treatment of chronic migraines: randomized, double-blind, controlled single-center experience. Pain Pract. 2017;17(5):669–77. This study showed 60% of patients received atleast 30 % reduction in pain at 52 weeks for chronic migraine, albeit in a smaller study of 20 patients.
•• Dodick DW, Silberstein SD, Reed KL, Deer TR, Slavin KV, Huh B, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2015;35(4):344–58. This is a long-term follow up study of Silberstein et al showing larger percentage patients received 30% pain relief but 70% of patients expericnced an adverse event during 12-month follow up.
Fontaine D, Blond S, Lucas C, Regis J, Donnet A, Derrey S, et al. Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: results of an observational prospective study. Cephalalgia. 2017;37(12):1173–9.
Rodrigo D, Acin P, Bermejo P. Occipital nerve stimulation for refractory chronic migraine: results of a long-term prospective study. Pain Physician. 2017;20(1):E151–E9.
Miller S, Watkins L, Matharu M. Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients. J Headache Pain. 2016;17(1):68.
Levin M. Nerve blocks in the treatment of headache. Neurotherapeutics. 2010;7(2):197–203.
Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry. 2008;79(4):415–7.
Naja ZM, El-Rajab M, Al-Tannir MA, Ziade FM, Tawfik OM. Occipital nerve blockade for cervicogenic headache: a double-blind randomized controlled clinical trial. Pain Pract. 2006;6(2):89–95.
•• Schoenen J, Jensen RH, Lanteri-Minet M, Láinez MJ, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33(10):816–30. This study showed 67% reduction in pain (vs 7.4%) with full stimulation on demand with acceptable safety profile.
Narouze SN. Role of sphenopalatine ganglion neuroablation in the management of cluster headache. Curr Pain Headache Rep. 2010;14(2):160–3.
Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg. 1997;87(6):876–80.
Narouze S, Kapural L, Casanova J, Mekhail N. Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache. 2009;49(4):571–7.
Salar G, Ori C, Iob I, Fiore D. Percutaneous thermocoagulation for sphenopalatine ganglion neuralgia. Acta Neurochir. 1987;84(1–2):24–8.
Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, et al. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20(2):85–91.
Ho KWD, Przkora R, Kumar S. Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review. J Headache Pain. 2017;18(1):118.
Manolitsis N, Elahi F. Pulsed radiofrequency for occipital neuralgia. Pain Physician. 2014;17(6):E709–17.
Asopa A. Systematic review of radiofrequency ablation and pulsed radiofrequency for management of cervicogenic headache. Pain Physician. 2015;18:109–30.
• Grandhi RK, Kaye AD. Abd-Elsayed a. systematic review of radiofrequency ablation and pulsed radiofrequency for management of cervicogenic headaches. Curr Pain Headache Rep. 2018;22(3):18. This comprehensive review shows that both techniques provide limited benefit and identifies an urgent need for a high quality RCT.
Abd-Elsayed A, Kreuger L, Wheeler S, Robillard J, Seeger S, Dulli D. Radiofrequency ablation of pericranial nerves for treating headache conditions: a promising option for patients. Ochsner J. 2018;18(1):59–62.
•• Cohen SP, Peterlin BL, Fulton L, Neely ET, Kurihara C, Gupta A, et al. Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness. Pain. 2015;156(12):2585–94. This study demonstrates greater reduction in pain up to 6 months with PRF compared to steroid injections, but analgesia was not accompanied by improvement in other outcome measures.
Odonkor CA, Tang T, Taftian D, Chhatre A. Bilateral intra-articular radiofrequency ablation for cervicogenic headache. Case Rep Anesthesiol. 2017;2017:1483279.
Fadayomi O, Kendall MC, Nader A. Ultrasound-guided pulsed radiofrequency of C2 dorsal root ganglion as adjuvant treatment for chronic headache disorders: a case report. A A Pract. 2018:1.
• Nagar VR, Birthi P, Grider JS, Asopa A. Systematic review of radiofrequency ablation and pulsed radiofrequency for management of cervicogenic headache. Pain Physician. 2015;18(2):109–30. Because of the lack of high quality studies (RCTs) this review showed limited evidence to show the benefit of RFA and PRF for cervicogenic headache.
Gabrhelik T, Michalek P, Adamus M. Pulsed radiofrequency therapy versus greater occipital nerve block in the management of refractory cervicogenic headache - a pilot study. Prague Med Rep. 2011;112(4):279–87.
Stovner LJ, Kolstad F, Helde G. Radiofrequency denervation of facet joints C2-C6 in cervicogenic headache: a randomized, double-blind, sham-controlled study. Cephalalgia. 2004;24(10):821–30.
Haspeslagh SR, Van Suijlekom HA, Lame IE, Kessels AG, van Kleef M, Weber WE. Randomised controlled trial of cervical radiofrequency lesions as a treatment for cervicogenic headache [ISRCTN07444684]. BMC Anesthesiol. 2006;6(1).
Lee JB, Park JY, Park J, Lim DJ, Kim SD, Chung HS. Clinical efficacy of radiofrequency cervical zygapophyseal neurotomy in patients with chronic cervicogenic headache. J Korean Med Sci. 2007;22(2):326–9.
van Suijlekom HA, van Kleef M, Barendse GA, Sluijter ME, Sjaastad O, Weber WE. Radiofrequency cervical zygapophyseal joint neurotomy for cervicogenic headache: a prospective study of 15 patients. Funct Neurol. 1998;13(4):297–303.
Govind J, King W, Bailey B, Bogduk N. Radiofrequency neurotomy for the treatment of third occipital headache. J Neurol Neurosurg Psychiatry. 2003;74(1):88–93.
•• Wang E, Wang D. Treatment of cervicogenic headache with cervical epidural steroid injection. Curr Pain Headache Rep. 2014;18(9):442. This article describes neuroanatomy, neurophysiology and classification of CGH and comprehensive review of the efficacy of cervical epidural steroid injections.
Martelletti P, Di Sabato F, Granata M, Alampi D, Apponi F, Borgonuovo P, et al. Epidural corticosteroid blockade in cervicogenic headache. Eur Rev Med Pharmacol Sci. 1998;2(1):31–6.
He MW, Ni JX, Guo YN, Wang Q, Yang LQ, Liu JJ. Continuous epidural block of the cervical vertebrae for cervicogenic headache. Chin Med J. 2009;122(4):427–30.
Mehnert MJ, Freedman MK. Update on the role of z-joint injection and radiofrequency neurotomy for cervicogenic headache. PM R. 2013;5(3):221–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ruchir Gupta, Kyle Fisher, and Srinivas Pyati declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Chronic Daily Headache
Rights and permissions
About this article
Cite this article
Gupta, R., Fisher, K. & Pyati, S. Chronic Headache: a Review of Interventional Treatment Strategies in Headache Management. Curr Pain Headache Rep 23, 68 (2019). https://doi.org/10.1007/s11916-019-0806-9
Published:
DOI: https://doi.org/10.1007/s11916-019-0806-9